Your browser doesn't support javascript.
loading
Electrically Controlled Vasodilator Delivery from PEDOT/Silica Nanoparticle Modulates Vessel Diameter in Mouse Brain.
Woeppel, Kevin M; Krahe, Daniela D; Robbins, Elaine M; Vazquez, Alberto L; Cui, Xinyan Tracy.
Afiliación
  • Woeppel KM; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
  • Krahe DD; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
  • Robbins EM; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
  • Vazquez AL; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
  • Cui XT; Center for Neural Basis of Cognition, University of Pittsburgh and Carnegie Mellon University, Pittsburgh, PA, 15261, USA.
Adv Healthc Mater ; 13(3): e2301221, 2024 Jan.
Article en En | MEDLINE | ID: mdl-37916912
ABSTRACT
Vascular damage and reduced tissue perfusion are expected to majorly contribute to the loss of neurons or neural signals around implanted electrodes. However, there are limited methods of controlling the vascular dynamics in tissues surrounding these implants. This work utilizes conducting polymer poly(ethylenedioxythiophene) and sulfonated silica nanoparticle composite (PEDOT/SNP) to load and release a vasodilator, sodium nitroprusside, to controllably dilate the vasculature around carbon fiber electrodes (CFEs) implanted in the mouse cortex. The vasodilator release is triggered via electrical stimulation and the amount of release increases with increasing electrical pulses. The vascular dynamics are monitored in real-time using two-photon microscopy, with changes in vessel diameters quantified before, during, and after the release of the vasodilator into the tissues. This work observes significant increases in vessel diameters when the vasodilator is electrically triggered to release, and differential effects of the drug release on vessels of different sizes. In conclusion, the use of nanoparticle reservoirs in conducting polymer-based drug delivery platforms enables the controlled delivery of vasodilator into the implant environment, effectively altering the local vascular dynamics on demand. With further optimization, this technology could be a powerful tool to improve the neural electrode-tissue interface and study neurovascular coupling.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vasodilatadores / Nanopartículas Límite: Animals Idioma: En Revista: Adv Healthc Mater Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vasodilatadores / Nanopartículas Límite: Animals Idioma: En Revista: Adv Healthc Mater Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos